About the Authors
- Ji Yun Lee
-
Roles Data curation, Formal analysis, Investigation, Visualization, Writing – original draft
Affiliations Department of Microbiology and Immunology, Western University, London, Ontario, Canada, Matthew Mailing Centre for Translational Transplant Studies, Lawson Health Research Institute, London, Ontario, Canada
- Shabitha Arumugarajah
-
Roles Formal analysis, Investigation, Writing – review & editing
Affiliations Department of Microbiology and Immunology, Western University, London, Ontario, Canada, Matthew Mailing Centre for Translational Transplant Studies, Lawson Health Research Institute, London, Ontario, Canada
- Dameng Lian
-
Roles Investigation, Methodology
Affiliation Matthew Mailing Centre for Translational Transplant Studies, Lawson Health Research Institute, London, Ontario, Canada
- Natsumi Maehara
-
Roles Investigation
Affiliation Centre for Disease Biology and Integrative Medicine, University of Tokyo, Tokyo, Japan
- Aaron R. Haig
-
Roles Formal analysis
Affiliation Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada
- Rita S. Suri
-
Roles Methodology, Writing – review & editing
Affiliation Faculty of Medicine, Division of Nephrology, McGill University, Montreal, Quebec, Canada
- Toru Miyazaki
-
Roles Investigation, Resources
Affiliation Centre for Disease Biology and Integrative Medicine, University of Tokyo, Tokyo, Japan
- Lakshman Gunaratnam
-
Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing
* E-mail: Lakshman.Gunaratnam@lhsc.on.ca
Affiliations Department of Microbiology and Immunology, Western University, London, Ontario, Canada, Matthew Mailing Centre for Translational Transplant Studies, Lawson Health Research Institute, London, Ontario, Canada, Division of Nephrology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada
Competing Interests
Dr. Toru Miyazaki holds a patent for the use of AIM for prevention or therapeutic agent for kidney disease (Issued in Japan [JP6460483], Korea [KOR10-1870246], and US [US10349640 B2]. This does not alter our adherence to PLOS ONE policies on sharing data and materials.The authors declare no other conflicts of interest with respect to this publication.